Abstract C117: Understanding the implications of CD36 expression in Hormone Receptor+/HER2- (HR+/HER2-) Drug Tolerant Persister breast cancer
Year: 2025
Type: conference-abstract
Source: Molecular Cancer Therapeutics
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W4415444589
Cites:
Cited by:
Related to:
